首页 | 本学科首页   官方微博 | 高级检索  
     

抗甲肝病毒基因工程单抗分离纯化与鉴定
引用本文:魏敬双 陶苒 孙巍巍 贾茜 李川 梁米芳. 抗甲肝病毒基因工程单抗分离纯化与鉴定[J]. 生物工程学报, 2004, 20(2): 257-261
作者姓名:魏敬双 陶苒 孙巍巍 贾茜 李川 梁米芳
作者单位:1. 华北制药集团新药研究开发有限责任公司,石家庄,050015
2. 中国疾病预防控制中心,北京,100052
基金项目:国家高技术研究发展计划 ( 86 3计划 )基金资助 (No .2 0 0 2AA2Z3339)~~
摘    要:为克服血源免疫球蛋白制品的不足,开发了抗甲肝病毒基因工程单克隆抗体anti-HAV IgG。用无血清培养基培养rCHO工程细胞株,上清液经过rProtein A SFF亲和层析→脱盐→离子交换层析→超滤换液纯化后,所得anti-HAV IgG纯度达99%以上,比活性约100IU/mg,anti-HAV IgG活性回收率40%。所纯化的anti-HAV IgG分子量150kD,等电点8.4~9.3。免疫印迹实验证实anti-HAV IgG为人源全抗体分子。亲和层析介质rProtein A SFF确实存在亲和配基脱落问题,但通过后续纯化步骤可有效除去。在亲和层析过程中加入高盐清洗步骤,可有效降低宿主DNA残留量水平。对样品中自由巯基含量进行了测定,认为非还原电泳图谱中低分子量条带是由于抗体分子内存在自由巯基引起。用该工艺制备的anti-HAV IgG各项纯度检测指标均达到我国对基因工程产品的质量要求。

关 键 词:重组人抗甲肝病毒单抗, 蛋白纯化, 亲和层析, rProtein A残留量

Purification and Characterization of Recombinant Human anti-HAV Monoclonal Antibody
Abstract. Purification and Characterization of Recombinant Human anti-HAV Monoclonal Antibody[J]. Chinese journal of biotechnology, 2004, 20(2): 257-261
Authors:Abstract
Affiliation:New Drug R&D Center, North China Pharmaceutical Corporation, Shijiazhuang 050015, China.
Abstract:In order to obviate the drawbacks o f plasma immunoglobulins, the whole molecular recombinant human anti_HAV (hepatitis A virus)monoclonal antibody (anti_HAV IgG) produced and secreted by rCHO cells was purified and its physicochemical properties were extensively c haracterized. The rCHO cells were cultured in serum_free medium and the supernat ants were collected. The recombinant human IgG molecules were sequentially purif ied by ultrafiltration, rProtein A Sepharose Fast Flow affinity chromatography, ion exchange chromatography and diafiltration. In affinity chromatography, prior to the target protein elution, an intermediate high salt wash step was inserted , different pH and salt concentrations were evaluated for the capacity of removi ng host cell DNA. The yield of the downstream purification process was approxima tely 40%. The purity of anti_HAV IgG thus generated was assayed with SEC_HPLC me thod, integration result showed that the monomeric IgG content was more than 99% . Western_blot was carried out with AP_antiHuman IgG (Fab specific) and AP_antiH uman IgG (Fc specific) respectively, the blot result demonstrated that the anti_ HAV IgG is human antibody with Fab and Fc structure. The specific anti_HAV activ ity determined by ELISA was 100 IU/mg, with anti_HAV immunoglobulin as the worki ng standard reference. Ligand leakage in the eluate of the affinity column was a pproximately 32 ng/mg IgG, while after further purification steps, it was decrea sed to less than 2 ng/mg IgG. Residual host cell DNA was monitored with solid do t blot assay, DNA can be removed effectively with intermediate high salt wash st ep in the affinity chromatography. Free sulfhydryl content of anti_HAV IgG was a ssayed with fluorescent spectrophotometer, the low molecular weight bands appear ed in non_reducing SDS_PAGE may be caused by the presence of free sulfhydryl. Th e endotoxin content was less than 1EU/mg examined by standard LAL test procedure s. Anti_HAV IgG prepared with this process is able to fulfill the regulatory req uirements of State Food and Drug Administration for recombinant products.
Keywords:recombinant human anti_HAV monoclonal antibody    protein purification   affinity chromatography   residual rProtein A content
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《生物工程学报》浏览原始摘要信息
点击此处可从《生物工程学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号